Compare LYFT Inc (LYFT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LYFT Inc vs State Street SPDR S&P Biotech ETF — how do they compare? LYFT Inc trades at $17.52 (market cap $6.64B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, LYFT Inc nearer its low. Which is the better fit depends on your goals.
| LYFT | XBI | |
|---|---|---|
Market Cap | $6.64B | — |
Sector | Industrials | Broad Market / Factor |
52-Week High | $24.57 | $164.28 |
52-Week Low | $12.65 | $86.92 |
Enterprise Value | $6.11B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
